Estrogen receptor-β expression in human laryngeal carcinoma: Correlation with the expression of epithelial-mesenchymal transition specific biomarkers

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1063-1068

  Goulioumis, Anastasios K ^a,c   Fuxe, Jonas ^c   Varakis, John ^a   Repanti, Maria ^b   Goumas, Panos ^a   Papadaki, Helen ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

catenin; E cadherin; Estrogen receptor (ER ); Laryngeal carcinoma; Vimentin

Indexed keywords

BETA CATENIN; CADHERIN; ESTROGEN RECEPTOR BETA;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CARCINOMA CELL; CELL JUNCTION; CELL NUCLEUS; CELLULAR DISTRIBUTION; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; EPITHELIAL CELLS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; MALE; MESODERM; MIDDLE AGED; PROGNOSIS; VIMENTIN;

EID: 70449377791     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000537     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002 CA Cancer J Clin 55: 74-108, 2005.
2. Gu D, Kelly TN, Wu X, et al: Mortality attributable to smoking in China. NEJM 360: 150-159, 2009.
3. Planas-Silva MD and Waltz PK: Estrogen promotes reversible epithelial to mesenchymal like transition and collective motility in MCF-7 breast cancer cells. J Ster Biochem Mol Biol 104: 211-217, 2007.
4. Fuchs M: Landmarks of physiological development of the voice in childhood and adolescence (part 1). Laryngorhinootologie 87: 10-16, 2008.
5. Yamashita S: Localization and functions of steroid hormone receptors. Histol Histopathol 13: 255-270, 1998.
6. Heldring N, Pike A, Andersson S, et al: Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87: 905-931, 2007.
7. Liu MM, Albanese C, Anderson CM, et al: Opposing action of estrogen receptors a and β on cyclin D1 gene expression. J Biol Chem 277: 24352-24360, 2002.
8. Helguero LA, Lindberg K, Gardmo C, Schwend T, Gustafsson JA and Haldosén LA: Different roles of estrogen receptors A and B in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line. Cancer Res 68: 8695-8704, 2008.
9. Prins GS and Korach KS: The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73: 233-244, 2008.
10. Di Leo A, Cavallini A and Linsalata M: Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 1: 1-12, 2001.
11. Ho SM, Leung YK and Chung I: Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann NY Acad Sci 1089: 177-193, 2006.
12. Ali S and Coombes RC: Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 5: 271-281, 2000.
13. Koehler KF, Helguero LA and Haldosén LA: Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 26: 465-478, 2005.
14. Järvinen TA, Pelto-Huikko M, Holli K and Isola J: Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156: 29-35, 2000.
15. Lazennec G: Estrogen receptor, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 231: 151-157, 2006.
16. Konstantinopoulos PA, Kominea A, Vandoros G, et al: Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39: 1251-1258, 2003.
17. Wu Y and Zhou BP: New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin 40: 643-650, 2008.
18. Moustakas A and Heldin CH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520, 2007.
19. Medici D, Hay ED and Goodenough DA: Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell 17: 1871-1879, 2006.
20. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal transition in human breast cancer - observations in vitro and in vivo. Cells Tissues Organs 185: 191-203, 2007.
21. Schmalhofer O, Brabletz S and Brabletz T: E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 1-2: 151-166, 2009.
22. Smalley MJ and Dale TC: Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev 18: 215-230, 1999.
23. Lopez-Gonzalez JS, Cristerna-Sanchez L, Vazquez-Manriquez ME, Jimenez-Orci G and Aguilar-Cazares D: Localization and level of expression of β-catenin in human laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 1: 89-93, 2004.
24. Rodrigo JP, Dominguez F, Suárez V, Canel M, Secades P and Chiara MD: Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Arch Otolaryngol Head Neck Surg 133: 145-150, 2007.
25. Park SH, Cheung LW, Wong AS and Leung PC: Estrogen regulates Snail and Slug in the downregulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 22: 2085-2098, 2008.
26. Cardesa A, Gale N, Nadal A, et al: Squamous cell carcinoma. In: World Health Organization Classification of Tumors, Pathology and Genetics of Head and Neck Tumors. L Barnes (ed). IARC Press, Lyon, pp118-121, 2005.
27. Hagedorn HG and Nerlich AG: Analysis of sex-hormone-receptor expression in laryngeal carcinoma. Eur Arch Otorhinolaryngol 259: 205-210, 2002.
28. Lukits J, Remenár E, Rásó E, Ladányi A, Kásler M and Tímár J: Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol 30: 155-160, 2007.
29. Mulholland DJ, Dedhar S, Goetzee GA and Nelson CC: Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis: Wnt You Like to Know? Endocr Rev 26: 898-915, 2005.
30. Hou X, Tan Y, Li M, Dey SK and Das SK: Canonical Wnt signaling is critical to estrogen mediated uterine growth. Mol Endocrinol 18: 3035-3048, 2004.
31. Ding JX, Feng YJ, Yao LQ, Yu M, Jin HY and Yin LH: The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail. Int J Oncol 30: 1069-1075, 2006.
32. Su Y and Simmen RCM: Soy isoflavone Genistein up-regulates epithelial adhesion molecule E-cadherin expression and attenuates β-catenin signaling in mammary epithelial cells. Carcinogenesis 30: 331-339, 2008.
33. Syed DN, Khan N, Afaq F and Mukhtar H: Chemoprevation of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16: 193-203, 2007.
34. Le Corre L, Chalabi N, Delort L, Bignon YJ and Bernard-Gallon DJ: Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res 49: 462-471, 2005.